RAILY AESMED (02135) has issued a positive profit alert, indicating a significant turnaround in its financial performance for the first half of the fiscal year ending June 30, 2026.

According to the company's announcement, the group expects to record revenue of approximately RMB 115 million for the six months ending June 30, 2026. This represents a substantial increase from the approximately RMB 85 million reported for the comparable period ending June 30, 2025.

Furthermore, the group anticipates a profit attributable to equity holders of the parent company of approximately RMB 4 million for the six-month period ending June 30, 2026. This contrasts sharply with the loss attributable to equity holders of the parent company of approximately RMB 8 million recorded for the same period in the prior year.

The board attributes the expected swing to profitability primarily to a rise in gross profit of about RMB 15 million, driven by increased revenue. This revenue growth was mainly fueled by (i) an expansion in revenue from medical aesthetic services; and (ii) a higher volume of sales of medical aesthetic equipment products.